RadioNano Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 9

RadioNano Therapeutics General Information

Description

Developer of nanoparticle-based boron neutron capture therapy drugs intended to treat cancer. The company's technology utilizes highly hydrophilic boron-containing inorganic nanoparticles and thermal neutron irradiation to provide selective cell destruction, high drug accumulation and localized energy release, enabling healthcare providers to destroy malignant cells while minimizing damage to healthy tissue.

Contact Information

Website
www.radionano-tx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 36-1, Yoshida Honmachi
  • Sakyo-ku
  • Kyoto, Kyoto Prefecture 606-8317
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Nanotechnology, Life Sciences, Oncology
Corporate Office
  • 36-1, Yoshida Honmachi
  • Sakyo-ku
  • Kyoto, Kyoto Prefecture 606-8317
  • Japan

RadioNano Therapeutics Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RadioNano Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 09-Oct-2026 Completed Clinical Trials - Phase 1
2. Accelerator/Incubator Completed Clinical Trials - General
1. Early Stage VC (Series A) 23-Dec-2024 $3.97M $3.97M Completed Clinical Trials - General
To view RadioNano Therapeutics’s complete valuation and funding history, request access »

RadioNano Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class A Preferred
To view RadioNano Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

RadioNano Therapeutics Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

RadioNano Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026005041-A1 Altered modified boron carbide particles and neutron capture therapy agent comprising same Pending 28-Jun-2024

RadioNano Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RadioNano Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mitsui Kinzoku Corporation Minority
Chushin Venture Capital Corporate Venture Capital Minority
CITIC Capital Asset Manager Minority
DBJ Capital Corporate Venture Capital Minority
Japan Science And Technology Agency Government Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

RadioNano Therapeutics FAQs

  • When was RadioNano Therapeutics founded?

    RadioNano Therapeutics was founded in 2024.

  • Where is RadioNano Therapeutics headquartered?

    RadioNano Therapeutics is headquartered in Kyoto, Japan.

  • What is the size of RadioNano Therapeutics?

    RadioNano Therapeutics has 10 total employees.

  • What industry is RadioNano Therapeutics in?

    RadioNano Therapeutics’s primary industry is Drug Discovery.

  • Is RadioNano Therapeutics a private or public company?

    RadioNano Therapeutics is a Private company.

  • What is RadioNano Therapeutics’s current revenue?

    The current revenue for RadioNano Therapeutics is .

  • How much funding has RadioNano Therapeutics raised over time?

    RadioNano Therapeutics has raised $3.97M.

  • Who are RadioNano Therapeutics’s investors?

    Mitsui Kinzoku, Chushin Venture Capital, CITIC Capital, DBJ Capital, and Japan Science And Technology Agency are 5 of 9 investors who have invested in RadioNano Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process